Tetra Bio-Pharma Inc.
TBP
Peringkat dalam Saham
#35436
Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical... Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical company focused on discovering and developing cannabinoid-based medications. Their efforts span several therapeutic areas, including inflammation, pain management, ophthalmology, and oncology. The company's pipeline features various drug candidates: PLENITUDE is being developed for cancer-related pain in advanced patients, while REBORN addresses breakthrough cancer pain. Reduvo is designed to combat chemotherapy-induced nausea and vomiting. ARDS-003 targets sepsis and the prevention of acute respiratory distress syndrome, and SERENITY aims to treat cancer cachexia. Furthermore, Tetra Bio-Pharma is advancing PPP003 for painful dry eye and uveitis pain, and HCC011 for hepatocellular carcinoma.
Harga Saham
$0.01851783
Terakhir disinkronkan: 2023-05-23
Kapitalisasi Pasar
$3.71M
Perubahan (1 hari)
-0.04%
Perubahan (1 tahun)
1,443.15%
Negara
CA
Perdagangan Tetra Bio-Pharma Inc. (TBP)
Kategori
Healthcare
Jumlah saham beredar untuk Tetra Bio-Pharma Inc. (TBP)
Jumlah saham beredar per October 2026: 0
Menurut laporan keuangan terbaru dan harga saham Tetra Bio-Pharma Inc., jumlah saham beredar saat ini adalah 0. Pada akhir October 2026, perusahaan memiliki 0 saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk Tetra Bio-Pharma Inc. (TBP) dari 2026 hingga 2026
Saham beredar pada akhir setiap tahun
| Tahun | Saham Beredar | Mengubah |
|---|---|---|
| Tidak cukup data untuk tanggal yang disediakan. | ||
Saham beredar untuk perusahaan serupa atau pesaing
| Perusahaan | Saham Beredar | Perbedaan | Negara |
|---|---|---|---|
| 253.90M | - |
US
|
|
| 396.00M | - |
US
|
|
| 478.91M | - |
AU
|
|
| - | - |
CH
|
|
| 62.19M | - |
NL
|
